companydata.dkZerion Pharma A/S
CVR: 40169229
Secondary names: Zerion A/S
Zerion Pharma A/S is currently facing significant financial challenges, with a negative profit trajectory and declining equity. In 2024, the company reported revenue of 3,452,016 DKK but incurred a loss of 220,020 DKK, following a substantial loss of over 11 million DKK in 2023. The equity position has deteriorated sharply, from -866,830 DKK in 2021 to -2,258,467 DKK in 2024, indicating increasing financial strain. While revenue has shown slight growth from 1.9 million DKK in 2021 to 3.5 million DKK in 2024, the persistent losses raise concerns about sustainability and operational efficiency in the competitive pharmaceutical manufacturing industry.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at drive virksomhed med udvikling af lægemidler samt enhver i forbindelse hermed stående virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 3.5 mio. | -220 t. | 9.7 mio. | -2.3 mio. | 12 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area